Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Company price
0.01 AUD 0.00(0%)
Last update at 2026-11-10T23:00:00Z
Market Cap
8.06M

Momentum Score

…

Careteq Limited engages in medication management and clinical governance for health, aged, and home care sectors in Australia. The company was incorporated in 2016 and is headquartered in Melbourne, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.01
Low
0.01
High
52 Week Price Range
0.01
Low
0.02
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Careteq Limited (ASX:CTQ) is limited; the company is listed as a healthcare-technology business. Long-term sector drivers that could support firms like Careteq include ageing populations, rising adoption of digital health systems and regulatory focus on care quality, which may benefit providers of clinical and administrative software solutions.
Material risks include limited public disclosure and small‑cap liquidity, execution and competitive pressures in health‑tech markets, and potential regulatory or funding changes that could materially affect growth prospects.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
6.08M
Revenue Per Share
0.02
Gross Profit TTM
1.07M
Debt / Equity
0.01
ROE
-16.75%
Net Debt
-3.14M
ROCE
-8.49%
Diluted EPS TTM
-

Stock Analysis

Insight Announcement

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax 0.70M -0.34M -1.42M -3.95M -5.25M
Minority interest - - -0.09M -0.21M -
Net income -0.40M -0.07M -2.67M -4.33M -5.25M
Selling general administrative - 0.93M 7.26M 8.27M 6.70M
Selling and marketing expenses - 0.00M - - -
Gross profit 5.79M 1.50M 6.74M 5.14M 4.14M
Reconciled depreciation - - 0.49M 0.44M 0.03M
Ebit -0.27M -0.07M -1.31M -3.93M -5.14M
Ebitda 0.01M 0.28M -0.83M -3.50M -5.10M
Depreciation and amortization 0.29M 0.34M 0.49M - 0.03M
Operating income -0.27M 0.23M -0.52M -4.76M -5.14M
Other operating expenses 6.36M 7.06M 7.75M 1.09M 9.34M
Interest expense 0.26M 0.27M 0.11M 0.02M 0.11M
Tax provision - -0.39M 0.33M 0.17M 0.00M
Interest income - 0.27M 0.11M 0.02M 1.15M
Net interest income - - -0.11M -0.02M -0.11M
Extraordinary items - -0.12M -0.82M - -
Income tax expense 1.10M 0.39M 0.33M 0.17M -0.11M
Total revenue 6.08M 7.62M 7.23M 5.52M 4.43M
Total operating expenses 6.07M 0.93M 7.23M - 9.06M
Cost of revenue 0.29M 6.13M 0.49M 0.38M 0.28M
Total other income expense net 0.97M -0.57M -0.90M 0.83M -0.23M
Net income from continuing ops - - -1.75M -4.12M -5.25M
Net income applicable to common shares - -0.07M -2.67M -4.33M -5.25M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 3.78M 5.94M 6.82M 7.57M 8.02M
Intangible assets 0.37M 0.75M - 3.24M 0.10M
Other current assets 0.08M 1.42M 0.65M 0.03M 0.03M
Total liab 0.55M 4.42M 3.30M 5.43M 1.72M
Total stockholder equity 3.23M 1.52M 1.97M 2.14M 6.30M
Deferred long term liab - - - 0.67M -
Other current liab 0.24M 1.37M 1.49M 1.50M 1.32M
Common stock 27.89M 25.49M 25.49M 22.96M 22.96M
Capital stock - - - 22.96M 22.96M
Retained earnings -24.92M -24.91M -24.03M -22.22M -17.89M
Other liab - - - 0.11M 0.08M
Good will - 1.73M 1.73M 2.00M 1.52M
Other assets - - - 0.76M 0.00M
Cash 3.19M 1.05M 1.25M 1.85M 4.50M
Total current liabilities 0.55M 3.13M 3.03M 3.70M 1.64M
Current deferred revenue - - 0.48M - -
Net debt -3.14M 1.33M -1.06M - -4.50M
Short term debt 0.05M 1.14M 0.07M 0.70M 0.00M
Short long term debt - - - 0.70M -
Short long term debt total 0.05M 2.37M 0.19M - -
Other stockholder equity - - 0.00M 1.40M 1.23M
Property plant equipment - - - 0.29M 0.01M
Total current assets 3.29M 3.23M 3.85M 4.19M 6.39M
Long term investments - - - 0.09M -
Net tangible assets - - - -0.18M 4.68M
Net receivables 0.02M 0.77M 1.95M 1.96M 1.02M
Long term debt - - - 0.02M -
Inventory - - - 0.24M 0.22M
Accounts payable 0.25M 0.62M 0.99M 0.86M 0.32M
Accumulated other comprehensive income 0.26M 0.94M 0.51M - 1.23M
Non currrent assets other 0.08M 0.09M 1.00M 0.09M -
Non current assets total 0.49M 2.71M 2.97M 3.38M 1.63M
Capital lease obligations - - - 0.25M -
Long term debt total - - - 0.20M 0.00M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - - -0.57M -0.80M -0.26M
Change to liabilities - - - 1.32M 0.30M
Total cashflows from investing activities 3.92M 0.12M -0.57M -0.80M -0.26M
Net borrowings - - -0.71M 0.69M 3.64M
Total cash from financing activities -0.28M 0.40M 1.27M 0.68M 8.81M
Change to operating activities - - - 0.02M 0.30M
Net income -0.40M -0.07M -1.84M -4.33M -5.25M
Change in cash 2.14M -0.21M -0.60M -2.65M 4.31M
Begin period cash flow 1.05M 1.25M 1.85M 4.50M 0.19M
End period cash flow 3.19M 1.05M 1.25M 1.85M 4.50M
Total cash from operating activities -1.50M -0.73M -1.30M -2.53M -4.24M
Issuance of capital stock - - 2.47M - 6.00M
Depreciation 0.29M 0.34M 0.49M 0.38M 0.01M
Other cashflows from investing activities - 0.49M -0.54M 0.08M -0.24M
Dividends paid - -0.09M -0.11M - -
Change to inventory - - 0.24M -0.02M -0.12M
Change to account receivables 0.50M - 0.01M -0.41M -1.07M
Sale purchase of stock - 0.00M -0.30M 0.00M -0.54M
Other cashflows from financing activities -0.08M - -0.08M -0.00M 3.80M
Change to netincome - - - 0.46M 1.58M
Capital expenditures 0.06M 0.07M 1.29M 0.17M 0.02M
Change in working capital -0.63M 0.01M 0.34M 1.03M 0.43M
Stock based compensation - 0.00M 0.02M - -
Other non cash items -0.76M -1.00M 0.20M - -
Free cash flow -1.56M -0.80M -2.59M -2.70M -0.02M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CTQ
Careteq Ltd
-
-%
0.01 - - 1.33 2.50 0.81 171.38
PME
Pro Medicus Ltd
-4.52
2.18%
202.79 81.98 106.38 83.13 43.70 74.38 95.34
4DX
4DMEDICAL Ltd
-0.06
2.53%
2.31 - - 205.57 8.53 170.03 -7.29
CGS
Cogstate Ltd
0.12
3.30%
3.76 33.80 27.86 9.59 6.95 6.35 19.27
AYA
ARTRYA Ltd
-0.14
3.91%
3.44 - - 20505.14 7.00 16927.51 0.33

Profile*

Careteq Ltd

Careteq Limited engages in medication management and clinical governance for health, aged, and home care sectors in Australia. The company was incorporated in 2016 and is headquartered in Melbourne, Australia.

99 Queen Street, Melbourne, VIC, Australia, 3000

61 3 9563 4212

Name Title Year Born
Mr. Mark Anthony Simari B.Acc, Dip FS Exec. Chairman 1969
Mr. Alexander Boyd COO & Exec. Director NA
Mr. David Lilja CFO & Company Sec. NA
Mr. Mark Anthony Simari B.Acc, Dip FS Executive Chairman 1969
Mr. Alexander Boyd COO & Executive Director NA
Mr. David Lilja M.B.A. CFO & Company Secretary NA
Mr. Mark Anthony Simari B.Acc, Dip FS Executive Chairman 1969
Mr. Alexander Boyd COO & Executive Director NA
Mr. David Lilja M.B.A. CFO & Company Secretary NA
Mr. Mark Anthony Simari B.Acc, Dip FS Executive Chairman 1969

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…